These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29742191)

  • 1. Gene Expression Analysis Differentiates Melanomas from Spitz Nevi.
    Jansen B; Hansen D; Moy R; Hanhan M; Yao Z
    J Drugs Dermatol; 2018 May; 17(5):574-576. PubMed ID: 29742191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
    Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
    J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
    Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
    Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Classification of Indeterminate Melanocytic Lesions by MicroRNA Profiling.
    Latchana N; Del Campo SE; Grignol VP; Clark JR; Albert SP; Zhang J; Wei L; Aldrink JH; Nicol KK; Ranalli MA; Peters SB; Gru A; Trihka P; Payne PR; Howard JH; Carson WE
    Ann Surg Oncol; 2017 Feb; 24(2):347-354. PubMed ID: 27469124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
    van Dijk MC; Bernsen MR; Ruiter DJ
    Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation between Spitz nevi and malignant melanomas by interphase fluorescence in situ hybridization.
    Wettengel GV; Draeger J; Kiesewetter F; Schell H; Neubauer S; Gebhart E
    Int J Oncol; 1999 Jun; 14(6):1177-83. PubMed ID: 10339676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRAME expression in melanocytic proliferations with intermediate histopathologic or spitzoid features.
    Raghavan SS; Wang JY; Kwok S; Rieger KE; Novoa RA; Brown RA
    J Cutan Pathol; 2020 Dec; 47(12):1123-1131. PubMed ID: 32700786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PRAME immunohistochemistry of spitzoid neoplasms.
    Koh SS; Lau SK; Scapa JV; Cassarino DS
    J Cutan Pathol; 2022 Aug; 49(8):709-716. PubMed ID: 35488519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and validation of a noninvasive 2-gene molecular assay for cutaneous melanoma.
    Gerami P; Yao Z; Polsky D; Jansen B; Busam K; Ho J; Martini M; Ferris LK
    J Am Acad Dermatol; 2017 Jan; 76(1):114-120.e2. PubMed ID: 27707590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell cycle and apoptosis regulators in Spitz nevi: comparison with melanomas and common nevi.
    Stefanaki C; Stefanaki K; Antoniou C; Argyrakos T; Patereli A; Stratigos A; Katsambas A
    J Am Acad Dermatol; 2007 May; 56(5):815-24. PubMed ID: 17437889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
    Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
    J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of BRAF gene mutations differentiates spitz nevi from malignant melanoma.
    Mihic-Probst D; Perren A; Schmid S; Saremaslani P; Komminoth P; Heitz PU
    Anticancer Res; 2004; 24(4):2415-8. PubMed ID: 15330192
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global microRNA profiling for diagnostic appraisal of melanocytic Spitz tumors.
    Latchana N; Regan K; Howard JH; Aldrink JH; Ranalli MA; Peters SB; Zhang X; Gru A; Payne PRO; Suarez-Kelly LP; Carson WE
    J Surg Res; 2016 Oct; 205(2):350-358. PubMed ID: 27664883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-reactivity of NRASQ61R antibody in a subset of Spitz nevi with 11p gain: a potential confounding factor in the era of pathway-based diagnostic approach.
    Parra O; Lefferts JA; Tafe LJ; Gru AA; Linos K
    Hum Pathol; 2021 Jun; 112():35-47. PubMed ID: 33636207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TRPM1 (Melastatin-1/MLSN1) mRNA expression in Spitz nevi and nodular melanomas.
    Erickson LA; Letts GA; Shah SM; Shackelton JB; Duncan LM
    Mod Pathol; 2009 Jul; 22(7):969-76. PubMed ID: 19396153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
    Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
    Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Spitz nevus and Reed nevus: simulating melanoma in adults].
    Paredes B; Hardmeier T
    Pathologe; 1998 Nov; 19(6):403-11. PubMed ID: 9885003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential diagnostic utility of PRAME and p16 immunohistochemistry in melanocytic nevi and malignant melanoma.
    Bahmad HF; Oh KS; Alexis J
    J Cutan Pathol; 2023 Aug; 50(8):763-772. PubMed ID: 37114299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Spitz nevi: a survey of dermatologists in the United States.
    Gelbard SN; Tripp JM; Marghoob AA; Kopf AW; Koenig KL; Kim JY; Bart RS
    J Am Acad Dermatol; 2002 Aug; 47(2):224-30. PubMed ID: 12140468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spitz nevi display allelic deletions.
    Bogdan I; Burg G; Böni R
    Arch Dermatol; 2001 Nov; 137(11):1417-20. PubMed ID: 11708943
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.